pentobarbital will reduce the level or impact of saxagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.pentobarbital will lessen the extent or outcome of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Monitor clients already on